Microneedling Market size is valued at USD 540.3 million in 2022 and is poised to grow at a significant CAGR of 7.9% over 2022–2028. Microneedling is a minimally invasive cosmetic procedure that uses small, sterilized needles to prick the skin. Dermatologists use microneedling therapy to generate new collagen and skin tissue to smooth, firm, and tone skin with the help of the body’s natural healing response. It is also known as collagen induction therapy. It helps in reducing the appearance of scars, including acne scars, wrinkles, enlarged pores, dark spots, and stretch marks. It also improves skin elasticity and promotes hair growth in people with alopecia. It’s considered safe for most people who are in overall good health and ideal results can be achieved after multiple sessions but may require a long-term maintenance plan. The growing popularity of minimally invasive technology, the high adoption rate of derma care therapies and products, and increasing investment in skin rejuvenating treatments at the global level will boost the market growth in the microneedling market. Moreover, rising aesthetic consciousness among consumers, awareness about the effectiveness of microneedling procedures, and availability of at-home microneedling devices are paving the path to a high adoption rate of microneedling therapies. According to a report, skin wrinkling was found to be 33%, 87.8%, and 100% in the young, middle-aged, and old groups, respectively. The youngest age for fine wrinkling to occur was 21 years. However, the high cost of microneedling therapies and no coverage insurance are hindering the overall market growth. Microneedling can cost anywhere from $200 to $800 per session. The overall costs depend on the size of the area being worked on, the number of sessions needed, and the professional’s specific rates. On the basis of region, North America held the major market share in 2022 and is expected to dominate the global market in the forecasted years.
Recent Market Developments:
In Oct 2021, Crown Aesthetics, a division of Crown Laboratories, Inc. and the global leader in microneedling technology, formally announced the launch of their SkinPen Ambassador Program.
In Feb 2020, Cynosure, the global leader in medical aesthetics, announced the U.S. Food and Drug Administration (FDA) clearance of the Potenza radiofrequency (RF) microneedling device, the first and only FDA-cleared four-mode RF microneedling device.
In April 2021, Cynosure announced the U.S. launch of its one-of-a-kind Fusion Tip, the newest addition to its best-in-class Potenza radiofrequency (RF) microneedling system.
In June 2021, Eclipse, a leading aesthetic and medical manufacturer announced FDA clearance of their latest medical-grade microneedling device, the MicroPen EVO.